Jul 17, 2023
Newsfile is ready to complete all of your filing needs once SEDAR+ launches on July 25th. Importantly, you should also know that prior to...
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Concert Pharmaceuticals, Inc. Buyout
January 19, 2023 1:28 PM EST | Source: Rigrodsky Law, P.A.
Wilmington, Delaware--(Newsfile Corp. - January 19, 2023) - Rigrodsky Law, P.A. is investigating Concert Pharmaceuticals, Inc. ("Concert") (NASDAQ: CNCE) regarding possible breaches of fiduciary duties and other violations of law related to Concert's agreement to be acquired by Sun Pharmaceutical Industries Limited.
To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-concert-pharmaceuticals-inc.
To contact Seth D. Rigrodsky or Gina M. Serra cost free, call or text (302) 295-5310 or email info@rl-legal.com.
Rigrodsky Law, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.
Attorney advertising. Prior results do not guarantee a similar outcome.
Contact:
Rigrodsky Law, P.A.
Seth D. Rigrodsky, Esq.
Gina M. Serra, Esq.
Call or Text: (302) 295-5310
Email: info@rl-legal.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/151912